Acquired Company
Merck acquired Pandion Therapeutics on 4/1/2021 for $60 per share in cash, representing a total equity value of about $1.85 billion.
Show more
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Start AI Chat
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$60.05
Open
$60.05
Volume
N/A
Day Range
$60.05 - $60.05
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
09/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|